Recommendations for cardiovascular magnetic resonance in adults with congenital heart disease from the respective working groups of the European Society of Cardiology

Philip J Kilner, Tal Geva, Harald Kaemmerer, Pedro T Trindade, Juerg Schwitter, Gary D Webb, Philip J Kilner, Tal Geva, Harald Kaemmerer, Pedro T Trindade, Juerg Schwitter, Gary D Webb

Abstract

This paper aims to provide information and explanations regarding the clinically relevant options, strengths, and limitations of cardiovascular magnetic resonance (CMR) in relation to adults with congenital heart disease (CHD). Cardiovascular magnetic resonance can provide assessments of anatomical connections, biventricular function, myocardial viability, measurements of flow, angiography, and more, without ionizing radiation. It should be regarded as a necessary facility in a centre specializing in the care of adults with CHD. Also, those using CMR to investigate acquired heart disease should be able to recognize and evaluate previously unsuspected CHD such as septal defects, anomalously connected pulmonary veins, or double-chambered right ventricle. To realize its full potential and to avoid pitfalls, however, CMR of CHD requires training and experience. Appropriate pathophysiological understanding is needed to evaluate cardiovascular function after surgery for tetralogy of Fallot, transposition of the great arteries, and after Fontan operations. For these and other complex CHD, CMR should be undertaken by specialists committed to long-term collaboration with the clinicians and surgeons managing the patients. We provide a table of CMR acquisition protocols in relation to CHD categories as a guide towards appropriate use of this uniquely versatile imaging modality.

Figures

Figure 1
Figure 1
Right ventricular volume measurement in CHD: several regions are challenging and need consistent approaches for comparison between studies. The images are from a patient after repair of tetralogy of Fallot with infundibular resection. (A) The short-axis stack (typically 6 mm slice thickness with 4 mm gaps) is shown relative to four-chamber cine. The most basal short-axis cine should be located just within the basal myocardium of the RV and LV at end diastole. However, the tricuspid annular plane (dotted line) may lie oblique to this slice, and usually moves through the first and often the second slice during systole. Care is needed to delineate areas of the ventricular but not the atrial cavities in the more basal slices. (B) A thin, akinetic region of the RVOT (arrowed in the sagittal RVOT view) should be regarded as part of the RV up to the (expected) level of the pulmonary valve. (C) In a mid-basal short-axis slice, the arrows indicate an akinetic region. A relatively smooth contour is drawn immediately inside the compact myocardium of the free wall, outside the trabeculations. (D) However, at end systole, hypertrophied trabeculations of the muscular part of the free wall may appear to merge (asterisk). The boundary line can still be located just inside the compact layer after viewing in cine mode. Alternatively, the dotted line drawn within the trabecular layer would give a slightly smaller end-systolic blood volume. (E) Trabeculations are numerous towards the apex of the RV and partial volume averaging blurs boundaries, so delineation outside the blood and trabeculations is probably the most reproducible approach. (F) Alternatively, tracing around the visible trabeculations at all levels may be more accurate, although not necessarily more reproducible between investigators and studies. The methods chosen need to be consistent for longitudinal comparison.
Figure 2
Figure 2
Pulmonary regurgitation measured by through-plane velocity mapping in repaired tetralogy of Fallot. (A) Cine imaging aligned with the RVOT showed no effective pulmonary valve, with unobstructed and expansile pulmonary arteries. (B) Mapping of velocities through a plane transecting the MPA showed (C) systolic forward flow, diastolic reversed flow, and late diastolic forward flow with atrial systole.

References

    1. Pennell DJ, Sechtem UP, Higgins CB, Manning WJ, Pohost GM, Rademakers FE, van Rossum AC, Shaw LJ, Yucel EK. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J. 2004;25:1940–1965.
    1. Perloff JK, Warnes CA. Challenges posed by adults with repaired congenital heart disease. Circulation. 2001;103:2637–2643.
    1. Dearani JA, Connolly HM, Martinez R, Fontanet H, Webb GD. Caring for adults with congenital cardiac disease: successes and challenges for 2007 and beyond. Cardiol Young. 2007;17:87–96.
    1. Niwa K, Perloff JK, Webb GD, Murphy D, Liberthson R, Warnes CA, Gatzoulis MA. Survey of specialized tertiary care facilities for adults with congenital heart disease. Int J Cardiol. 2004;96:211–216.
    1. Warnes CA. Transposition of the great arteries. Circulation. 2006;114:2699–2709.
    1. Gewillig M. The Fontan circulation. Heart. 2005;91:839–846.
    1. Fratz S, John H, Annika S, Christine B, Eva H, Stefan M, Heiko S. Routine clinical cardiovascular magnetic resonance in paediatric and adult congenital heart disease: patients, protocols, questions asked and contributions made. J Cardiovasc Magn Reson. 2008;10:46.
    1. Schwitter J. 1st ed. Zurich, Switzerland: Juerg Scwitter; 2008. CMR-Update.
    1. Bluemke DA, Achenbach S, Budoff M, Gerber TC, Gersh B, Hillis LD, Hundley WG, Manning WJ, Printz BF, Stuber M, Woodard PK. Noninvasive coronary artery imaging: magnetic resonance angiography and multidetector computed tomography angiography: a scientific statement from the American Heart Association committee on cardiovascular imaging and intervention of the council on cardiovascular radiology and intervention, and the councils on clinical cardiology and cardiovascular disease in the young. Circulation. 2008;118:586–606.
    1. Nicol ED, Gatzoulis M, Padley SP, Rubens M. Assessment of adult congenital heart disease with multi-detector computed tomography: beyond coronary lumenography. Clin Radiol. 2007;62:518–527.
    1. Nicol ED, Kafka H, Stirrup J, Padley SP, Rubens MB, Kilner PJ, Gatzoulis MA. A single, comprehensive non-invasive cardiovascular assessment in pulmonary arterial hypertension: Combined computed tomography pulmonary and coronary angiography. Int J Cardiol. 2009;136:278–288.
    1. Einstein AJ, Moser KW, Thompson RC, Cerqueira MD, Henzlova MJ. Radiation dose to patients from cardiac diagnostic imaging. Circulation. 2007;116:1290–1305.
    1. Sadetzki S. Excess lifetime cancer mortality risk attributed to radiation exposure from pediatric computed tomography scan. Isr Med Assoc J. 2007;9:607–609.
    1. Einstein AJ, Henzlova MJ, Rajagopalan S. Estimating risk of cancer associated with radiation exposure from 64-slice computed tomography coronary angiography. J Am Med Assoc. 2007;298:317–323.
    1. Gerber TC, Carr JJ, Arai AE, Dixon RL, Ferrari VA, Gomes AS, Heller GV, McCollough CH, McNitt-Gray MF, Mettler FA, Mieres JH, Morin RL, Yester MV. Ionizing radiation in cardiac imaging: a science advisory from the American Heart Association Committee on Cardiac Imaging of the Council on Clinical Cardiology and Committee on Cardiovascular Imaging and Intervention of the Council on Cardiovascular Radiology and Intervention. Circulation. 2009;119:1056–1065.
    1. Babu-Narayan SV, Kilner PJ, Li W, Moon JC, Goktekin O, Davlouros PA, Khan M, Ho SY, Pennell DJ, Gatzoulis MA. Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of Fallot and its relationship to adverse markers of clinical outcome. Circulation. 2006;113:405–413.
    1. Wernovsky G, Rome JJ, Tabbutt S, Rychik J, Cohen MS, Paridon SM, Webb G, Dodds KM, Gallagher MA, Fleck DA, Spray TL, Vetter VL, Gleason MM. Guidelines for the outpatient management of complex congenital heart disease. Congenit Heart Dis. 2006;1:10–26.
    1. Williams RG, Pearson GD, Barst RJ, Child JS, del Nido P, Gersony WM, Kuehl KS, Landzberg MJ, Myerson M, Neish SR, Sahn DJ, Verstappen A, Warnes CA, Webb CL National Heart, Lung, Blood Institute Working Group on research in adult congenital heart disease. Report of the National Heart, Lung, and Blood Institute Working Group on research in adult congenital heart disease. J Am Coll Cardiol. 2006;47:701–707.
    1. Helbing WA, Mertens L, Sieverding L. Recommendations from the Association for European Paediatric Cardiology for training in congenital cardiovascular magnetic resonance imaging. Cardiol Young. 2006;16:410–412.
    1. Sanders SP, Colan SD, Cordes TM, Donofrio MT, Ensing GJ, Geva T, Kimball TR, Sahn DJ, Silverman NH, Sklansky MS, Weinberg PM. ACCF/AHA/AAP recommendations for training in pediatric cardiology. Task force 2: pediatric training guidelines for noninvasive cardiac imaging endorsed by the American Society of Echocardiography and the Society of Pediatric Echocardiography. J Am Coll Cardiol. 2005;46:1384–1388.
    1. Pohost GM, Kim RJ, Kramer CM, Manning WJ. Task Force 12: training in advanced cardiovascular imaging (cardiovascular magnetic resonance [CMR]) endorsed by the Society for Cardiovascular Magnetic Resonance. J Am Coll Cardiol. 2008;51:404–408.
    1. van den Bosch AE, Robbers-Visser D, Krenning BJ, McGhie JS, Helbing WA, Meijboom FJ, Roos-Hesselink JW. Comparison of real-time three-dimensional echocardiography to magnetic resonance imaging for assessment of left ventricular mass. Am J Cardiol. 2006;97:113–117.
    1. Mannaerts HF, Van Der Heide JA, Kamp O, Papavassiliu T, Marcus JT, Beek A, Van Rossum AC, Twisk J, Visser CA. Quantification of left ventricular volumes and ejection fraction using freehand transthoracic three-dimensional echocardiography: comparison with magnetic resonance imaging. J Am Soc Echocardiogr. 2003;16:101–109.
    1. Grothues F, Smith GC, Moon JC, Bellenger NG, Collins P, Klein HU, Pennell DJ. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol. 2002;90:29–34.
    1. Bellenger NG, Marcus NJ, Rajappan K, Yacoub M, Banner NR, Pennell DJ. Comparison of techniques for the measurement of left ventricular function following cardiac transplantation. J Cardiovasc Magn Reson. 2002;4:255–263.
    1. Karamitsos T, Hudsmith L, Selvanayagama J, Neubauer S, Francis J. Operator induced variability in left ventricular measurements with cardiovascular magnetic resonance is improved after training. J Cardiovasc Mag Reson. 2007;9:777–783.
    1. Mooij CF, de Wit CJ, Graham DA, Powell AJ, Geva T. Reproducibility of MRI measurements of right ventricular size and function in patients with normal and dilated ventricles. J Magn Reson Imaging. 2008;28:67–73.
    1. Winter MM, Bernink FJ, Groenink M, Bouma BJ, van Dijk AP, Helbing WA, Tijssen JG, Mulder BJ. Evaluating the systemic right ventricle by CMR: the importance of consistent and reproducible delineation of the cavity. J Cardiovasc Magn Reson. 2008;10:40.
    1. Codella NC, Weinsaft JW, Cham MD, Janik M, Prince MR, Wang Y. Left ventricle: automated segmentation by using myocardial effusion threshold reduction and intravoxel computation at MR imaging. Radiology. 2008;248:1004–1012.
    1. Plein S, Schwitter J, Suerder D, Greenwood JP, Boesiger P, Kozerke S. k-Space and time sensitivity encoding-accelerated myocardial perfusion MR imaging at 3.0 T: comparison with 1.5 T. Radiology. 2008;249:493–500.
    1. Muthurangu V, Taylor A, Andriantsimiavona R, Hegde S, Miquel ME, Tulloh R, Baker E, Hill DL, Razavi RS. Novel method of quantifying pulmonary vascular resistance by use of simultaneous invasive pressure monitoring and phase-contrast magnetic resonance flow. Circulation. 2004;110:826–834.
    1. Muthurangu V, Razavi RS. The value of magnetic resonance guided cardiac catheterisation. Heart. 2005;91:995–996.
    1. Geva T, Marshall AC. Magnetic resonance imaging-guided catheter interventions in congenital heart disease. Circulation. 2006;113:1093–1100.
    1. Prakash A, Powell AJ, Krishnamurthy R, Geva T. Magnetic resonance imaging evaluation of myocardial perfusion and viability in congenital and acquired pediatric heart disease. Am J Cardiol. 2004;93:657–661.
    1. Levine GN, Gomes AS, Arai AE, Bluemke DA, Flamm SD, Kanal E, Manning WJ, Martin ET, Smith JM, Wilke N, Shellock FS American Heart Association Committee on Diagnostic Interventional Cardiac Catheterization; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Cardiovascular Radiology, Intervention. Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance. Circulation. 2007;116:2878–2891.
    1. Shellock FG, Spinazzi A. MRI safety update 2008: part 2, screening patients for MRI. Am J Roentgenol. 2008;191:1140–1149.
    1. Penfield JG. Nephrogenic systemic fibrosis and the use of gadolinium-based contrast agents. Pediatr Nephrol. 2008;23:2121–2129.
    1. Canavese C, Mereu MC, Aime S, Lazzarich E, Fenoglio R, Quaglia M, Stratta P. Gadolinium-associated nephrogenic systemic fibrosis: the need for nephrologists' awareness. J Nephrol. 2008;21:324–336.
    1. Shellock FG, Spinazzi A. MRI safety update 2008: part 1, MRI contrast agents and nephrogenic systemic fibrosis. AJR Am J Roentgenol. 2008;191:1129–1139.
    1. Royal College of Radiologists advice on gadolinium-based contrast media and nephrogenic systemic fibrosis: .
    1. Odegard KC, DiNardo JA, Tsai-Goodman B, Powell AJ, Geva T, Laussen PC. Anaesthesia considerations for cardiac MRI in infants and small children. Paediatr Anaesth. 2004;14:471–476.
    1. Kilner PJ, Gatehouse PD, Firmin DN. Flow measurement by magnetic resonance: a unique asset worth optimising. J Cardiovasc Magn Reson. 2007;9:723–728.
    1. Davos D, Kilner PJ. Calculations of cardiovascular shunts and regurgitation using magnetic resonance ventricular volume and aortic and pulmonary flow measurements. European Radiology. 2009 Epub ahead of print.
    1. Chernobelsky A, Shubayev O, Comeau CR, Wolff SD. Baseline correction of phase contrast images improves quantification of blood flow in the great vessels. J Cardiovasc Magn Reson. 2007;9:681–685.
    1. Lankhaar JW, Hofman MB, Marcus JT, Zwanenburg JJ, Faes TJ, Vonk-Noordegraaf A. Correction of phase offset errors in main pulmonary artery flow quantification. J Magn Reson Imaging. 2005;22:73–79.
    1. Wagner A, Mahrholdt H, Kim RJ, Judd RM. Use of cardiac magnetic resonance to assess viability. Curr Cardiol Rep. 2005;7:59–64.
    1. Gerber BL, Raman SV, Nayak K, Epstein FH, Ferreira P, Axel L, Kraitchman DL. Myocardial first-pass perfusion cardiovascular magnetic resonance: history, theory, and current state of the art. J Cardiovasc Magn Reson. 2008;10:18.
    1. Bonow RO, Carabello BA, Kanu C, de Leon AC, Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SC, Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B. ACC/AHA Guidelines for the Management of Patients with Valvular Heart disease. Circulation. 2006;114:e84–e231.
    1. Gabriel RS, Kerr AJ, Raffel OC, Stewart RA, Cowan BR, Occleshaw CJ. Mapping of mitral regurgitant defects by cardiovascular magnetic resonance in moderate or severe mitral regurgitation secondary to mitral valve prolapse. J Cardiovasc Magn Reson. 2008;10:16.
    1. Chan KM, Wage R, Symmonds K, Rahman-Haley S, Mohiaddin RH, Firmin DN, Pepper JR, Pennell DJ, Kilner PJ. Towards comprehensive assessment of mitral regurgitation using cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2008;10:61.
    1. Carr-White GS, Kilner PJ, Hon JK, Rutledge T, Edwards S, Burman ED, Pennell DJ, Yacoub MH. Incidence, location, pathology, and significance of pulmonary homograft stenosis after the Ross operation. Circulation. 2001;104:I16–I20.
    1. Crowe ME, Rocha CA, Wu E, Carr JC. Complications following the Ross procedure: cardiac MRI findings. J Thorac Imaging. 2006;21:213–218.
    1. Klieverik LM, Takkenberg JJ, Bekkers JA, Roos-Hesselink JW, Witsenburg M, Bogers AJ. The Ross operation: a Trojan horse? Eur Heart J. 2007;28:1993–2000.
    1. Therrien J, Thorne SA, Wright A, Kilner PJ, Somerville J. Repaired coarctation: a ‘cost-effective’ approach to identify complications in adults. J Am Coll Cardiol. 2000;35:997–1002.
    1. Chessa M, Carrozza M, Butera G, Piazza L, Negura DG, Bussadori C, Bossone E, Giamberti A, Carminati M. Results and mid-long-term follow-up of stent implantation for native and recurrent coarctation of the aorta. Eur Heart J. 2005;26:2728–2732.
    1. Hassan W, Awad M, Fawzy ME, Omrani AA, Malik S, Akhras N, Shoukri M. Long-term effects of balloon angioplasty on left ventricular hypertrophy in adolescent and adult patients with native coarctation of the aorta. Up to 18 years follow-up results. Catheter Cardiovasc Interv. 2007;70:881–886.
    1. Steffens JC, Bourne MW, Sakuma H, O'Sullivan M, Higgins CB. Quantification of collateral blood flow in coarctation of the aorta by velocity encoded cine magnetic resonance imaging. Circulation. 1994;90:937–943.
    1. Nielsen JC, Powell AJ, Gauvreau K, Marcus EN, Prakash A, Geva T. Magnetic resonance imaging predictors of coarctation severity. Circulation. 2005;111:622–628.
    1. Connolly HM, Huston J, III, Brown RD, Jr, Warnes CA, Ammash NM, Tajik AJ. Intracranial aneurysms in patients with coarctation of the aorta: a prospective magnetic resonance angiographic study of 100 patients. Mayo Clin Proc. 2003;78:1491–1499.
    1. Fattori R, Bacchi Reggiani L, Pepe G, Napoli G, Bna C, Celletti F, Lovato L, Gavelli G. Magnetic resonance imaging evaluation of aortic elastic properties as early expression of Marfan syndrome. J Cardiovasc Magn Reson. 2000;2:251–256.
    1. Kaemmerer H, Oechslin E, Seidel H, Neuhann T, Neuhann IM, Mayer HM, Hess J. Marfan syndrome: what internists and pediatric or adult cardiologists need to know. Expert Rev Cardiovasc Ther. 2005;3:891–909.
    1. Baumgartner D, Baumgartner C, Matyas G, Steinmann B, Loffler-Ragg J, Schermer E, Schweigmann U, Baldissera I, Frischhut B, Hess J, Hammerer I. Diagnostic power of aortic elastic properties in young patients with Marfan syndrome. J Thorac Cardiovasc Surg. 2005;129:730–739.
    1. Knirsch W, Kurtz C, Häffner N, Binz G, Heim P, Winkler P, Baumgartner D, Freund-Unsinn K, Stern H, Kaemmerer H, Molinari L, Kececioglu D, Uhlemann F. Dural ectasia in children with Marfan syndrome: a prospective, multicenter, patient-control study. Am J Med Genet A. 2006;140:775–781.
    1. Apitz C, Webb GD, Redington AN. Tetralogy of Fallot. Lancet. 2009 [Epub ahead of print]
    1. Davlouros PA, Kilner PJ, Hornung TS, Li W, Francis JM, Moon JC, Smith GC, Tat T, Pennell DJ, Gatzoulis MA. Right ventricular function in adults with repaired tetralogy of Fallot assessed with cardiovascular magnetic resonance imaging: detrimental role of right ventricular outflow aneurysms or akinesia and adverse right-to-left ventricular interaction. J Am Coll Cardiol. 2002;40:2044–2052.
    1. Dorfman AL, Geva T. Magnetic resonance imaging evaluation of congenital heart disease: conotruncal anomalies. J Cardiovasc Magn Reson. 2006;8:645–659.
    1. Samyn MM, Powell AJ, Garg R, Sena L, Geva T. Range of ventricular dimensions and function by steady-state free precession cine MRI in repaired tetralogy of Fallot: right ventricular outflow tract patch vs. conduit repair. J Magn Reson Imaging. 2007;26:934–940.
    1. Wald RM, Redington AN, Pereira A, Provost YL, Paul NS, Oechslin EN, Silversides CK. Refining the assessment of pulmonary regurgitation in adults after tetralogy of Fallot repair: should we be measuring regurgitant fraction or regurgitant volume? Eur Heart J. 2009;30:356–361.
    1. Henkens IR, van Straten A, Schalij MJ, Hazekamp MG, de Roos A, van der Wall EE, Vliegen HW. Predicting outcome of pulmonary valve replacement in adult tetralogy of Fallot patients. Ann Thorac Surg. 2007;83:907–911.
    1. Geva T. Indications and timing of pulmonary valve replacement after tetralogy of Fallot repair. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2006;9:11–22.
    1. Frigiola A, Tsang V, Bull C, Coats L, Khambadkone S, Derrick G, Mist B, Walker F, van Doorn C, Bonhoeffer P, Taylor AM. Biventricular response after pulmonary valve replacement for right ventricular outflow tract dysfunction: is age a predictor of outcome? Circulation. 2008;118:S182–S190.
    1. Harrild DM, Berul CI, Cecchin F, Geva T, Gauvreau K, Pigula F, Walsh EP. Pulmonary valve replacement in tetralogy of Fallot: impact on survival and ventricular tachycardia. Circulation. 2009;119:445–451.
    1. Lurz P, Coats L, Khambadkone S, Nordmeyer J, Boudjemline Y, Schievano S, Muthurangu V, Lee TY, Parenzan G, Derrick G, Cullen S, Walker F, Tsang V, Deanfield J, Taylor AM, Bonhoeffer P. Percutaneous pulmonary valve implantation: impact of evolving technology and learning curve on clinical outcome. Circulation. 2008;117:1964–1972.
    1. Frigiola A, Tsang V, Nordmeyer J, Lurz P, van Doorn C, Taylor AM, Bonhoeffer P, de Leval M. Current approaches to pulmonary regurgitation. Eur J Cardiothorac Surg. 2008;34:576–580.
    1. Therrien J, Provost Y, Merchant N, Williams W, Colman J, Webb G. Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am J Cardiol. 2005;95:779–782.
    1. Oosterhof T, van Straten A, Vliegen HW, Meijboom FJ, van Dijk AP, Spijkerboer AM, Bouma BJ, Zwinderman AH, Hazekamp MG, de Roos A, Mulder BJ. Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Circulation. 2007;116:545–551.
    1. Geva T, Sahn DJ, Powell AJ. Magnetic resonance imaging of congenital heart disease in adults. Prog Pediatr Cardiol. 2003;17:21–39.
    1. Kilner PJ, Balossino R, Dubini G, Babu-Narayan SV, Taylor AM, Pennati G, Migliavacca F. Pulmonary regurgitation: the effects of varying pulmonary artery compliance, and of increased resistance proximal or distal to the compliance. Int J Cardiol. 2009;133:157–166.
    1. Chaturvedi RR, Redington AN. Pulmonary regurgitation in congenital heart disease. Heart. 2007;93:880–889.
    1. Geva T, Sandweiss BM, Gauvreau K, Lock JE, Powell AJ. Factors associated with impaired clinical status in long-term survivors of tetralogy of Fallot repair evaluated by magnetic resonance imaging. J Am Coll Cardiol. 2004;43:1068–1074.
    1. Kilner PJ, Sievers B, Meyer GP, Ho SY. Double-chambered right ventricle or sub-infundibular stenosis assessed by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2002;4:373–379.
    1. Geva T, Greil GF, Marshall AC, Landzberg M, Powell AJ. Gadolinium-enhanced 3-dimensional magnetic resonance angiography of pulmonary blood supply in patients with complex pulmonary stenosis or atresia: comparison with x-ray angiography. Circulation. 2002;106:473–478.
    1. Nagendran J, Michelakis E. MRI: one-stop shop for the comprehensive assessment of pulmonary arterial hypertension? Chest. 2007;132:2–5.
    1. Wald RM, Powell AJ. Simple congenital heart lesions. J Cardiovasc Magn Reson. 2006;8:619–631.
    1. Piaw CS, Kiam OT, Rapaee A, Khoon LC, Bang LH, Ling CW, Samion H, Hian SK. Use of non-invasive phase contrast magnetic resonance imaging for estimation of atrial septal defect size and morphology: a comparison with transesophageal echo. Cardiovasc Intervent Radiol. 2006;29:230–234.
    1. Valente AM, Sena L, Powell AJ, Del Nido PJ, Geva T. Cardiac magnetic resonance imaging evaluation of sinus venosus defects: comparison to surgical findings. Pediatr Cardiol. 2007;28:51–56.
    1. Salehian O, Schwerzmann M, Merchant N, Webb GD, Siu SC, Therrien J. Assessment of systemic right ventricular function in patients with transposition of the great arteries using the myocardial performance index: comparison with cardiac magnetic resonance imaging. Circulation. 2004;110:3229–3233.
    1. Taylor AM, Dymarkowski S, Hamaekers P, Razavi R, Gewillig M, Mertens L, Bogaert J. MR coronary angiography and late-enhancement myocardial MR in children who underwent arterial switch surgery for transposition of great arteries. Radiology. 2005;234:542–547.
    1. Rutledge JM, Nihill MR, Fraser CD, Smith OE, McMahon CJ, Bezold LI. Outcome of 121 patients with congenitally corrected transposition of the great arteries. Pediatr Cardiol. 2002;23:137–145.
    1. Garg R, Powell AJ, Sena L, Marshall AC, Geva T. Effects of metallic implants on magnetic resonance imaging evaluation of Fontan palliation. Am J Cardiol. 2005;95:688–691.
    1. Grosse-Wortmann L, Al-Otay A, Yoo SJ. Aortopulmonary collaterals after bidirectional cavopulmonary connection or Fontan completion: quantification with MRI. Circ Cardiovasc Imaging. 2009;2:219–225.
    1. Anderson RH, Becker AE, Freedom RM, Macartney FJ, Quero-Jimenez M, Shinebourne EA, Wilkinson JL, Tynan M. Sequential segmental analysis of congenital heart disease. Pediatr Cardiol. 1984;5:281–287.
    1. Van Praagh R, Santini F, Geva T. Segmental situs in congenital heart disease: a fundamental concept. G Ital Cardiol. 1990;20:246–253.
    1. Taylor AM, Thorne SA, Rubens MB, Jhooti P, Keegan J, Gatehouse PD, Wiesmann F, Grothues F, Somerville J, Pennell DJ. Coronary artery imaging in grown-up congenital heart disease: complementary role of MR and X-ray coronary angiography. Circulation. 2000;101:1670–1678.
    1. Bunce NH, Lorenz CH, Keegan J, Lesser J, Reyes EM, Firmin DN, Pennell DJ. Coronary artery anomalies: assessment with free-breathing three-dimensional coronary MR angiography. Radiology. 2003;227:201–208.
    1. Valsangiacomo Buechel ER, Balmer C, Bauersfeld U, Kellenberger CJ, Schwitter J. Feasibility of perfusion cardiovascular magnetic resonance in paediatric patients. J Cardiovasc Reson Med. 2009;11:51–59.
    1. Schwitter J, Wacker CM, van Rossum AC, Lombardi M, Al-Saadi N, Ahlstrom H, Dill T, Larsson HBW, Flamm SD, Marquardt M, Johansson L. MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J. 2008;29:480–489.

Source: PubMed

3
Sottoscrivi